Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells.

导出 LinkOut

翻译打印收藏纠错

第一作者： Liyun,Niu

第一单位： State Key Laboratory of Drug Metabolism and Pharmacokinetics, Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, 100850, China.

作者： Liyun,Niu ^[1] ; Huiyu,Zhou ^[1] ; Yueru,Lian ^[2] ; Ya,Gao ^[1] ; Yulu,Liu ^[1] ; Ruolan,Gu ^[1] ; Zhuona,Wu ^[1] ; Xiaoxia,Zhu ^[1] ; Hui,Gan ^[1] ; Zhiyun,Meng ^[1] ; Guifang,Dou ^[1]

作者单位： State Key Laboratory of Drug Metabolism and Pharmacokinetics, Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing, 100850, China. ^[1] Henan University, Kaifeng, Henan, 475004, China. ^[2]

关键词 HRMS Metabolic stability Metabolites identification PEP06

DOI 10.1016/j.jpha.2022.03.002

PMID 36320606

发布时间 2022-11-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of pharmaceutical analysis

2022年12卷5期

766-773页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells.

Journal of pharmaceutical analysis

相似文献

Journal of pharmaceutical analysis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells.

Journal of pharmaceutical analysis

相似文献

Journal of pharmaceutical analysis

相关期刊

检索历史清除